Ameritas Investment Partners’s HilleVax HLVX Stock Holding History

Ameritas Investment Partners’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,714	Closed	-$3.94K	–	3257
2025 Q1	$3.94K	Hold	2,714	–	–	﹤0.01%	3017
2024 Q4	$5.62K	Hold	2,714	–	–	﹤0.01%	3012
2024 Q3	$4.78K	Hold	2,714	–	–	﹤0.01%	3045
2024 Q2	$39.2K	Hold	2,714	–	–	﹤0.01%	2273
2024 Q1	$45.1K	Hold	2,714	–	–	﹤0.01%	2202
2023 Q4	$43.6K	Buy	2,714 +961	+55%	+$12.8K	﹤0.01%	2249
2023 Q3	$23.6K	Hold	1,753	–	–	﹤0.01%	2463
2023 Q2	$30.1K	Buy	1,753 +781	+80%	+$12.1K	﹤0.01%	2328
2023 Q1	$16.1K	Hold	972	–	–	﹤0.01%	2539
2022 Q4	$14.6K	Hold	972	–	–	﹤0.01%	2678
2022 Q3	$16K	Hold	972	–	–	﹤0.01%	2623
2022 Q2	$10K	Buy	+972	New	+$11.5K	﹤0.01%	2830

Other funds holding HLVX

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

LMC

Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ameritas Investment Partners's HLVX Position: Q2 2025 in Review

Ameritas Investment Partners sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 2,714 shares — an estimated $3.94K sold.

Ameritas Investment Partners first reported a position in HLVX in Q2 2022 and held it in 12 quarters. The position peaked at $45.1K in Q1 2024. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

Ameritas Investment Partners reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 2,714 HilleVax shares in Q2 2025, an estimated $3.94K.
Ameritas Investment Partners first reported a position in HilleVax in Q2 2022 and held it in 12 quarters.
Ameritas Investment Partners's HilleVax position peaked at $45.1K in Q1 2024.
74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.